Human-Relevant Discovery: iPSC Models and the Future of Rare Disease R&D
A Q&A with iXCells Biotechnologies CEO, Steve Smith
02/25/2026
8 min read
Interview
False
Advertisement
Related Content
Outsourcing
Supply Chain
Interviews
The Barriers Limiting Radiopharmaceutical Access
September 21, 2026
5 min read
From isotope supply to reimbursement, the practical challenges shaping real-world delivery in oncology
Small Molecules
Development & Clinical
Interviews
Musings from The Power List: Dajun Yang
September 15, 2026
4 min read
The Ascentage Pharma CEO on why next-generation small molecules are expanding into territory once reserved for biologics
Small Molecules
Drug Discovery
Development & Clinical
Musings from The Power List: Ali Tavassoli
September 10, 2026
8 min read
Ali Tavassoli explains how cyclic peptides and new discovery tools are opening up once-inaccessible biology
Cell & Gene
Drug Discovery
Development & Clinical
Musings from The Power List: Miguel Forte
September 8, 2026
4 min read
Scientific progress alone isn't enough, says Miguel Forte, who argues that reimbursement and patient access will shape the next decade of cell and gene therapy